Phase 2b Study in NASH to Assess IVA337

PHASE2CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

February 7, 2017

Primary Completion Date

February 20, 2020

Study Completion Date

March 16, 2020

Conditions
Non-Alcoholic Steatohepatitis (NASH)
Interventions
DRUG

IVA337

1200mg

DRUG

IVA337

800mg

DRUG

Placebo

Placebo to match

Trial Locations (85)

1070

Hopital Erasme, Brussels

1090

Medical University Vienna, Vienna

1200

Clinique Universitaire Saint-luc, Brussels

Klin Med S.R.O., Prague

2650

Antwerp University Hospital, Edegem

3168

Monash Medical Centre, Clayton

6900

Epatocentro Ticino, Lugano

10126

A.O. Città della Salute e della Scienza di Torino, Torino

14021

Institut klinické a experimentální medicíny, IKEM, Prague

19107

Jefferson University hospital, Philadelphia

20122

Granda Ospedale Maggiore Policlinico - Università di Milano, Milan

22908

University of Virginia Health System, Charlottesville

23298

Virginia Commonwealth University, Richmond

25000

CHRU Besançon, Besançon

27710

Duke University Medical Center, Durham

28078

Carolina's Center for Liver Disease/CHG, Huntersville

28222

Hospital Puerta de Hierro MAJADAHONDA, Madrid

29010

Virgen de la Victoria University Hospital, Málaga

29027

Northeast GI Research Division, Concord

30100

Researchsite S.R.O., Pilsen

33016

Palmetto Research, LLC, Hialeah

34211

Florida Digestive Health Specialists, LLP, Lakewood Rch

35758

North Alabama GI Research Center, Madison

37076

Digestive Health Research, LLC, Hermitage

39008

Hospital Universitario Marqués de Valdecilla, Santander

41013

Hospital Virgen del Rocío, Seville

49933

CHU Angers, Angers

52074

RWTH University Hospital, Aachen

55131

Universitätsmedizin Mainz, I. Med. Klinik, Mainz

60126

Ospedali Riuniti di Ancona-Università Politecnica delle Marche, Ancona

69120

Medizinischen Klinik IV, Heidelberg

75012

Hôpital Saint Antoine, Paris

75013

Hôpital La Pitié Salpétrière, Paris

78215

The Texas Liver Institute, San Antonio

78229

Digestive Health Research, LLC, San Antonio

90057

National Research Institute, Los Angeles

90127

Pol. Giaccone, Palermo

92037

ACTRI, La Jolla

97080

University Hospital Würzburg, Würzburg

SA 5042

Flinders Medical Centre Department of Hepatology, Bedford Park

SA 5112

Lyell McEwin Hospital & The University of Adelaide, Elizabeth Vale

Unknown

Royal Brisbane and Women's Hospital, Herston

Ziekenhuis Oost Limburg, Genk

UZ Gent, Ghent

"DCC Alexandrovska, EOOD", Sofia

Acibadem City Clinic Tokuda Hospital, Sofia

Acibadem City Clinic University Hospital EOOD, Sofia

"MHAT Sveta Anna Sofia", Sofia

Military Medical Academy - MHAT, Sofia

"UMHAT Sv. Ivan Rilski", Sofia

"UMHAT Tsaritsa Yoanna-ISUL", Sofia

University of Calgary, Calgary

The Bailey Health Clinic, Edmonton

CISSS de la Montérégie Centre, Greenfield Park

University of Western Ontario, London Health Sciences Centre, London

McGill University Health Centre (MUHC), Montreal

Medpharmgene, Inc, Montreal

LAIR Centre, Vancouver

Centre Hospitalier de Bordeaux, Bordeaux

CHU Henri Mondor, Créteil

CHU de Grenoble, Grenoble

Hôpital de La Croix Rousse, Lyon

Centre Hospitalier Régional Universitaire de Montpellier, Montpellier

Hôpital Beaujon, Paris

Centre Hospitalier Universitaire de Rennes, Rennes

Hôpital de Hautepierre, Strasbourg

Hôpital Purpan - Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse

Innere Medizin II - Universitätsklinik Freiburg, Freiburg im Breisgau

Universitätsklinikum Münster, Münster

Poliambulatorio Giovanni Paolo II, San Giovanni Rotondo

CAP Research, Quatre Bornes

Oddzial Gastroenterologii Hepatologii UCK, Katowice

Centrum Badan Klinicznych, Wroclaw

General hospital Celje, Celje

General Hospital Murska Sobota, Murska Sobota

Vall d'Hebron Hospital, Barcelona

Universitätsklinik für Viszerale Chirurgie und Medizin, Bern

Kings College Hospital NHS Foundation Trust, London

Nottingham University Hospitals NHS Trust, Nottingham

WA 6150

Fiona Stanley Hospital, Murdoch

06202

CHU de Nice, Nice

00168

Fondazione Policlinico Agostino Gemelli, Roma

91-347

Katedra i Klinika Chorób Zakaźnych i Hepatologii Uniwersytetu Medycznego w Łodzi, Lodz

20-081

Klinika Chorób Zakaźnych, Lublin

NE7 7DN

Freeman Hospital, Newcastle University, Newcastle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Inventiva Pharma

INDUSTRY

NCT03008070 - Phase 2b Study in NASH to Assess IVA337 | Biotech Hunter | Biotech Hunter